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1. Introduction
Amphetamine and its derivatives: methampheta-
mine, 3,4-methylenedioxymethamphetamine (MDMA), 
3,4-methylenedioxyamphetamine MDA, p-metoxyamp-
hetamine (PMA), p-metoxymethamphetamine (PMMA)
are stimulants of the central nervous system. All of the
above substances are abused. EMCDDA (European Moni-
toring Centre for Drugs and Drug Addiction) estimated to-
tal production of ATS (amphetamine type stimulants) in
2005 around 520 tons.1
Amphetamine (1-phenylpropan-2-amine) also known
as šspeed’ causes strong physical and mental stimulation.
The abusers become alert, full of self-confidence, happy
and talkative. They may feel like having more energy and
being stronger. When the effect diminishes, their feelings
evolve into anxiety, fatigue, disinterest or tiredness.2 Amp-
hetamine is produced mainly in Europe. The Leuckart reac-
tion is the most common method used to obtain ampheta-
mine, but in some cases reductive amination of 1-phenyl-
propan-2-one (BMK or P2P) is used. The other synthetic
methods such as oxime or phenylnitropropene routes have
not been put into practice in illegal production.3,4
Methamphetamine (N-methyl-1-phenyl-propan-2-
amine) named šcrystal’, šcrank’, šmeth’, šYaba’ (tablets
containing mainly methamphetamine and caffeine)5,6 have
a more pronounced stimulatory effect on the central ner-
vous system than amphetamine. The high doses of this
drug can result in effects such as hallucinations, paranoia
and mania.2 The main production centres are placed in
East and South Asia.1
The drugs known as šecstasy’, šXTC’, šBeans’ and
šAdam’5 in 80% cases contain MDMA. However, their
composition exhibits substantial variability. In tablets, the
following substances: MDA, PMMA, PMA, amphetamine
and methamphetamine, ephedrine, ketamine and caffeine
were discovered beside MDMA.7–11 Production of ecstasy
tablets is concentrated in Europe but manufacture spreads
to other parts of the world: North America, East and South-
East Asia.1 Reductive amination of 1-(3,4-methylene-
dioxyphenyl)-2-propanone (MDP-2-P or PMK) was found
to be the most frequently used synthesis method of MD-
MA. Apart from this method the nitropropene route and sa-
frole bromination were encountered. The Leuckart reac-
tion to prepare MDMA was seldom used.4,12–14 MDMA in-
duce feelings such as euphoria, friendliness, closeness and
empathy. But when used frequently, especially in high do-
ses, it may cause cardiac arrhythmias, hyperthermia, lead
to dysfunction of kidney, liver and brain damage.8
The analysis of seized drug tablets or powder is usu-
ally carried out using chromatographic methods: GC,15–19
HPLC,9,20 or TLC.20,17,24 Other methods, e.g. near-infrared
spectroscopy and Raman spectroscopy have also been ap-
plied.21,22
TLC is a low-cost and very versatile technique due
to the availability of a wide range of possible developing
systems. A great variety of visualizing reagents for detec-
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The derivatisation solution was prepared by adding
20 µL of 98% phenyl isothiocyanate (PTIC) to 200 µL 2-
propanol. The mixture was completed with 20 µL distilled
water and 20 µL phosphate buffer pH 12 (3,58 g Na2HPO4
were dissolved in 80 mL water and the mixture was adju-
sted to pH = 12 with 1 mol L–1 NaOH and filled up by di-
stilled water to 100 mL).
Marquis agent was prepared by mixing one part of 38%
formaldehyde with five parts of 98% sulphuric acid (v/v). 
Simon agent was composed of two solutions (A and
B): 2% aqueous solution of sodium carbonate made solu-
tion A; solution B was prepared by dissolving 5 g of so-
dium nitroferricyanide in 100 mL of 10% acetaldehyde
solution. The plate was first sprayed with solution A and
then solution B. 
Ehrlich agent was a 1% solution of p-dimethyloami-
nobenzaldehyde in mixture of hydrochloric acid and met-
hanol (1:1 v/v). 
FBK solution was prepared by dissolving 0.5 g of Fast
Black K salt (C14H12N5O4 ⋅ 0.5ZnCl4) in 100 mL of water.
Ninhydrin solution was prepared by dissolving 0.2 g of
ninhydrin in 100 mL of ethanol. All solution used in visuali-
zation of the spots on a chromatogram were prepared daily. 
2.2. Procedure of Derivatisation 
of Amphetamine and Its Analogues 
A portion (1 µL) of drug solution was spotted on
TLC plate. Then, on the same place 1 µL derivatisation
agent (PTIC) was applied. Next, the plate was put in the
TLC chamber in order to complete the derivatisation pro-
cess. After 20 min, the plate was developed with mixture
of suitable solvents.
2.3. TLC Procedure
TLC silica gel 60F254 aluminium sheets (Merck,
Germany; 10 × 10 cm, 0.2 mm thin layer) were used for
determination of detection limits of amphetamine and its
analogues. The plates were developed in the horizontal
chamber (Camag, Switzerland). The developing distance
was 8 cm. After derivatisation, the analytes were sepera-
ted using the following mobile phase: n-hexane, toluene,
1,4-dioxane (3: 3: 1 v/v/v) which made System I. In case
the derivatisation was not carried out, another eluent was
used: 1,4-dioxane, methanol, chloroform and 25% aque-
ous ammonia (6: 2: 2: 1 v/v/v/v) – System II. After deve-
lopment the plates were dried at 100 °C for 15 min. Then
suitable spraying agents were applied.
2.4. Visualization of Spots on TLC Plates
The UV254 Procedure 
After drying, the developed plates in System I and II
were observed under UV lamp (254 nm). The substances
quenched fluorescence of the plate background.
tion of amphetamines in TLC was reported. Apart from
observation of spots under UV light (254 nm), ninhy-
drin23,24 and Marquis reagents9,25 are most often applied.
Also fluorescamine spray,23 iodoplatinate solution were
used.15,23 Ojanpera et.al. detected amphetamines with Fast
Black K (FBK) salt.26
In the present paper a new visualization and identifi-
cation of selected drugs components (amphetamine, met-
hamphetamine, MDMA, MDA, PMMA and PMA) is des-
cribed. The procedure is based on iodine azide reaction.
Its efficiency (detection limits) was compared with other
visualization methods in which the following reagents
were used: ninhydrin, FBK solutions, Marquis, Simon’s
and Ehrlich’s reagents as well as iodine vapour were used.
The iodine azide reaction proceeds according to the
following scheme:
This reaction had been successfully used for detection
of amino acids and biogenic amines on TLC plate.27,28 Woo
et. al. had applied the iodine-azide reaction to detect amino
acids in HPLC, as well.29,30 Only sulphur(II) compounds in-
duce the reaction. Because the analytes tested in the present
work do not include sulphur atoms in their molecules, they
need to be transformed into sulphur derivatives. Phenyl isot-
hiocyanate (PTIC) was selected as the derivatisation agent.
The derivatisation is a pre-chromatographic step and is per-
formed directly on TLC plate. After development, the plate
was sprayed with freshly prepared mixture of sodium azide
(adjusted to proper pH) and 0.5% starch solution. Then
the plate was exposed to iodine vapour. The plate back-
ground became violet-grey and the spots white.
2. Experimental
2.1. Solutions and Reagents
The following amines: MDMA (3,4-methylene-
dioxymethamphetamine), amphetamine and methamphe-
tamine, MDA (3,4-methylenedioxyamphetamine), PM-
MA (p-methoxy-methamphetamine), PMA (p-methox-
yamphetamine) used in the examination were synthesized
in our laboratory. The examined drugs were dissolved in
phosphate buffer pH = 7 (Merck. Germany).
Methanol, chloroform, 1,4-dioxane, n-hexane, 25%
aqueous ammonia (all Merck, Germany, HPLC grade), to-
luene (Eurochem BGD, Poland, analytical grade) were
used to prepare the mobile phases.
The spraying agent (iodine-azide reaction) was pre-
pared by dissolving 2 g of sodium azide in 20 mL of distil-
led water and next adding 25 mL of 0.5% starch solution.
Then, the pH of the mixture was adjusted (5.5–6.0) using
36% hydrochloride acid solution and diluted to 50 mL
with distilled water.
I2 + 2N3
– —————→ 2I– + 3N2.
C=S inductor
The Iodine Procedure
After drying, the developed plates in System I and II
were exposed to iodine vapour for 5 min. The drugs beca-
me visible as brown spots on yellow background of the
plate.
The Iodine-Azide Procedure
After drying, the developed plates (System I) we-
re sprayed with mixture containing sodium azide solu-
tion (spraying agent) and then exposed to iodine vapour
for 5 s. Due to catalytic effect of the C=S bond on the
iodine azide reaction, the examined compounds were
visible as white spots on the violet-grey background.
The colour of the plate has been stable for several mi-
nutes. 
Application of Marquis Reagent
After drying, the developed plates (System II) were
immersed in Marquis reagent and washed with distilled
water. The spots were dyed blue-green.
Application of Simon and Ehrlich Reagents
After drying, the developed plates (System II) were
sprayed with Simon or Ehrlich reagents and dried at 100
°C. The Simon reagent dyed the spots of drugs grey-
green. In the case Ehrlich reagent was applied, the back-
ground became yellow and the spots white.
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Table 1. Rf and detection limits (nmol per spot) of amphetamines detected as PTC-derivatives; mobile
phase – System I.
Compounds Rf Visualization procedure
iodine-azide procedure iodine vapour UV254
Amphetamine 0.44 0.19 0.19 0.19
Methamphetamine 0.45 0.17 0.17 0.17
MDMA 0.39 0.08 0.13 0.13
MDA 0.37 0.09 0.14 0.14
PMMA 0.42 0.15 0.15 0.15
PMA 0.40 0.14 0.14 0.14
Application of FBK and Ninhydrin Solutions
After drying, the developed plates (in System II)
were sprayed with ninhydrin or FBK solution and dried at
temperature in range 100–110 °C. In the case ninhydrin
reagent was used the purple-red spots on slight pink back-
ground were observed. The FBK dyed the spots red in the
case of secondary amines and violet in the case of primary
amines.
3. Results and Discussion
PTIC used as a derivatisation agent transforms ami-
nes to phenyl thiocarbamyl derivatives. This is why a dif-
ferent mobile phase has to be used.
In Tables 1 and 2, the values of Rf and detection li-
mits for amphetamines are compared, corresponding to
different visualization methods, after derivatisation of
analytes.
The application of iodine azide reaction as the vi-
sualization method gave the best results. Apart from the
low detection limits, an advantage of this visualization
system over other methods (iodine vapour and UV254),
was the quality of the obtained chromatogram. The spots
appeared more visible better shaped, observed as white
spots on a violet-grey background, as compared with ot-
her examined methods.
Table 2. Rf and detection limits (nmol per spot) of amphetamines (without derivatisation; mobile phase – System II).
Compounds Rf Visualization methods
UV254 iodine Ninhydrin FBK Marquis Simon's Ehrlich's 
vapour reagent reagent reagent
Amphetamine 0.51 18.5 12.4 9.3 9.3 - 3.4 18.5
Methamphetamine 0.42 16.8 11.2 8.4 8.4 - 1.7 –
MDMA 0.41 8.6 8.6 6.5 6.5 2.6 1.3 –
MDA 0.52 9.3 9.3 7.0 7.0 2.8 2.8 13.4
PMMA 0.37 9.3 9.3 7.0 7.0 - 1.4 –
PMA 0.49 10.1 10.1 7.6 7.6 - 3.0 15.2
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In Table 2, the detection limits obtained without deri-
vatisation are presented. In some cases, limits of detection
exceeded even by two orders the limits presented in Table
1, e.g. amphetamine detected under UV light or MDMA
using ninhydrin as compared with iodine-azide procedure.
The iodine-azide procedure was successfully ap-
plied in determination of MDMA in samples that were
synthesized in our laboratory according to various re-
ceipts which are used in clandestine laboratories.12,14 The
samples obtained from isosafrol and piperonal were stu-
died. On TLC plate MDMA spot (Rf = 0.39) was accom-
panied by spots that came from derivatisation agent.
4. Conclusions
It has been shown that derivatisation of amphetamine
and its analogues with phenyl isothiocyanate, a pre-chro-
matographic step in thin layer chromatography, makes it
possible to decrease detection limits of all tested drugs as
compared with other usually used methods of visualization
of spots on TLC chromatograms, applied without derivati-
sation. Also, it was shown that visualization procedure ba-
sed on iodine azide reaction belongs among the most sen-
sitive methods of detection of amphetamines after their de-
rivatisation. Though in the present paper only the most po-
pular drugs were tested, it may turn out that the procedure
proposed will be effective for other amphetamine analo-
gues and other drugs that contain amine group as well.
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Povzetek
Za detekcijo amfetaminov in analogov pri tenkoplastni kromatografiji smo uporabili derivatizacijo, ki ji sledi reakcija z
jodovim in azidom. Derivatizacijsko reakcijo s fenil izotiocianatom smo izvedli neposredno na plo{~i pred razvijanjem.
Naknadno smo plo{~e napr{ili z me{anico natrijevega azida in raztopine {kroba in jih nato izpostavili param joda. Meje
dolo~ljivosti smo primerjali z drugimi obi~ajnimi tehnikami vizualizacije: UV, jodove pare, reagenti po Marquisu and
Simonu, ninhidrin, Fast Black K.
